Insider trades
Frank X. Leonard, CEO of NovoCure NVCR, has filed 0 purchases and 36 sales on the open market. Over the past 12 months that comes to a net sale of $919.7K. The latest trade was on 06/04.
Frank X. Leonard
CEO
- Company
- NovoCure NVCR
- First filing
- 23/03/02
- Trades
- 60 trades
- Buys / sales
- 0 / 36
- 12-month net buying
- −$919.7K
- Last trade
- 06/04
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
NovoCureNVCR | Open-market sale | 06/04 | 06/05 | 34,273 sh | $17.93 | $614,514.89 | −6.9% |
NovoCureNVCR | Open-market sale | 03/04 | 03/05 | 5,607 sh | $13.31 | $74,629.17 | −1.1% |
NVCR | Open-market sale | 02/27–03/02 | 03/03 | 16,966 sh2 trades | $13.59avg. | $230,526.12 | −4.6% |
NVCR | Open-market sale10b5-1 plan | 25/06/02 | 25/06/04 | 30,196 sh3 trades | $17.50avg. | $528,420.53 | −15.2% |
NovoCureNVCR | Open-market sale | 25/03/03 | 25/03/04 | 2,527 sh | $18.54 | $46,850.58 | −1.7% |
NVCR | Open-market saleAmendment | 25/02/27–25/02/28 | 25/03/03 | 30,072 sh6 trades | $19.70avg. | $592,454.78 | −17.1% |
NovoCureNVCR | Open-market sale | 24/11/01 | 24/11/04 | 598 sh | $15.94 | $9,532.12 | −0.4% |
NVCR | Open-market sale | 24/03/01–24/03/04 | 24/03/05 | 2,519 sh2 trades | $16.02avg. | $40,362.77 | −1.5% |
NovoCureNVCR | Open-market sale | 24/02/28 | 24/02/29 | 2,078 sh | $16.14 | $33,538.92 | −1.3% |
NVCR | Open-market sale | 23/03/03–23/03/07 | 23/03/07 | 13,609 sh4 trades | $75.55avg. | $1,028,178.41 | −20.0% |
NVCR | Open-market sale | 23/03/02–23/03/03 | 23/03/06 | 2,903 sh2 trades | $76.95avg. | $223,397.08 | −4.1% |
NVCR | Open-market sale | 23/03/02 | 23/03/03 | 4,107 sh2 trades | $75.37avg. | $309,564.08 | −6.5% |
NovoCureNVCR | Open-market sale | 23/03/01 | 23/03/02 | 1,684 sh | $76.36 | $128,590.24 | −2.6% |
NVCR | Open-market sale | 23/01/05 | 23/01/09 | 39,507 sh9 trades | $112.25avg. | $4,434,656.23 | −46.1% |